Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Milton Park: Vale of White Horse District Council and MEPC to review Milton Park Local Development Order to meet 2040 Vision and respond to climate emergency

Vale of White Horse District Council and MEPC Milton Park in Oxfordshire, one of Europe’s largest science and technology communities, have agreed to review the Local Development Order (LDO) to help bring more sustainable investment to the park.  

Read the rest of entry »

Diamond Pharma Services: ProPharma Group Announces the Acquisition of Diamond Pharma Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, announces the acquisition of Diamond Pharma Services. Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and compliance & quality services to support pharmaceutical and biotechnology companies in obtaining and maintaining medicinal product licenses throughout all stages of a product’s life cycle.

Read the rest of entry »

OBN Announces FOCUS Oxford Risk Management Ltd and Partners& as New OBN Corporate Sponsor

Abingdon, UK; 9 March 2021 - OBN, the Membership organisation supporting the UK’s innovative life sciences companies, is pleased to announce FOCUS Oxford Risk Management Ltd and Partners& as OBN’s new Corporate Sponsor.

Read the rest of entry »

Air Products: Is it time to upgrade from aluminium storage container freezers to a larger automated freezer?

Often, research projects or sample storage facilities will start small, using just one or two containers - often referred to as ‘dewars’ - to store a few samples. As the facility grows, more and more containers are added until you have a makeshift cryo-room which probably looks something like the above image.

Read the rest of entry »

The Oxford Science Park: Immunometabolism company Sitryx expands into new space at TOSP

Sitryx, a company which is focused on regulating cell metabolism to develop disease-modifying therapeutics in inflammatory diseases and immuno-oncology, announces that it has expanded into new premises in the Bellhouse Building at The Oxford Science Park (TOSP), one of the UK’s leading parks for science and technology companies.

Read the rest of entry »

The Oxford Trust: £0.5 million Headington life science laboratory development at The Oxford Trust’s Innovation Centre supported by funding secured by OxLEP

The Oxford Trust, the local charity encouraging the pursuit of science and enterprise, is to undertake a half million-pound project to install life science laboratory facilities at its Wood Centre for Innovation in Headington, Oxford, to increase capacity for the local innovation ecosystem and has received £0.1 million in funding towards the project via the Government’s Local Growth Fund, secured by the Oxfordshire Local Enterprise Partnership (OxLEP).

 

Read the rest of entry »

Milton Park: Emergex Vaccines expands at Milton Park

Emergex Vaccines, which focuses on the development of synthetic T-cell vaccines against global infectious disease threats such as COVID-19, Dengue fever, Zika, Ebola and pandemic Flu, has expanded at Milton Park in Oxfordshire, one of Europe’s largest science and technology communities.

Read the rest of entry »

AMSBIO: Breast Cancer Cell Line Array 

AMSBIO announce a new HER2 control cell line array that was developed and is proven as an effective slide quality control for HER2 expression in breast cancer tissue samples.

This new FFPE cell pellet microarray delivers a full dynamic range of HER2, ER and PR expression, validated by the Ventana system, to give immunohistochemical data in strong concordance with the routinely processed tissue sample.sections.

Read the rest of entry »

Genomics plc completes oversubscribed $30m funding round

Genomics plc, a pioneering healthcare company that uses large-scale genetic information to develop innovative precision healthcare tools, is pleased to announce that it has successfully completed a $30m funding round.

Read the rest of entry »

WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers

WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the acquisition of OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy technologies. This acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and development of cutting-edge cell and gene therapies for patients in need worldwide.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.